wsbdaily | Tue, 20 Dec 2022 03:11:24 EST Where you find Tomorrow’s Hot Stocks Yesterday!
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Canadian Imperial Bank of Commerce(CM.TO)
Summary & Charts
| Price | $ 55.44 | -0.22 (-0.4%) |
| Day's Range | $ 55.03 - 55.82 | |
| Previous Close | $ 55.66 | |
| Market Cap | $ 50.24B CAD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | Toronto | |
| Industry | Banks—Diversified | |
| Sector | Financial Services | |
| Volume | 10.60M | |
| Avg. Volume (20 day) | 4.52M | |
| Rel. Volume (20 day) | 2.34 | |
| Rel. Volume (3 month) | 2.85 | |
| Rating | S- | Strong Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 1779.99 % | Strong Buy |
| ROE | 12.85 % | Neutral |
| ROA | 0.66 % | Neutral |
| P/E | 8.30 % | Strong Buy |
| P/B | 1.00 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | $ 55.28 | $ 55.82 | $ 55.03 | $ 55.44 | -0.22 | 10,601,357 | 2.34 | 2.85 | 3 |
| Dec 15, 2022 | $ 56.00 | $ 56.09 | $ 55.38 | $ 55.66 | -0.43 | 6,359,221 | 1.55 | 1.70 | 2 |
| Dec 14, 2022 | $ 56.55 | $ 57.06 | $ 56.07 | $ 56.09 | -0.36 | 6,790,570 | 1.73 | 1.85 | 4 |
| Dec 13, 2022 | $ 58.08 | $ 58.34 | $ 56.10 | $ 56.45 | -1.15 | 10,117,749 | 2.76 | 2.77 | 1 |
| Dec 12, 2022 | $ 58.06 | $ 58.29 | $ 56.90 | $ 57.60 | -0.92 | 6,956,281 | 2.10 | 1.97 | |
| Dec 09, 2022 | $ 57.90 | $ 58.65 | $ 57.89 | $ 58.52 | +0.32 | 3,360,217 | 1.07 | 0.96 | 1 |
| Dec 08, 2022 | $ 59.05 | $ 59.19 | $ 57.89 | $ 58.20 | -0.76 | 3,108,899 | 1.00 | 0.89 | 1 |
| Dec 07, 2022 | $ 58.74 | $ 59.13 | $ 58.44 | $ 58.96 | +0.09 | 2,525,093 | 0.81 | 0.73 | |
| Dec 06, 2022 | $ 59.00 | $ 59.20 | $ 58.31 | $ 58.87 | +0.05 | 3,639,066 | 1.18 | 1.06 | 2 |
| Dec 05, 2022 | $ 59.40 | $ 59.54 | $ 58.38 | $ 58.82 | -0.57 | 6,033,044 | 2.05 | 1.77 | |
| Dec 02, 2022 | $ 59.00 | $ 59.88 | $ 58.72 | $ 59.39 | -0.42 | 3,332,515 | 1.22 | 1.00 | 8 |
| Dec 01, 2022 | $ 62.75 | $ 62.92 | $ 59.40 | $ 59.81 | -4.98 | 7,209,695 | 2.70 | 2.18 | 6 |
| Nov 30, 2022 | $ 64.09 | $ 64.85 | $ 63.55 | $ 64.79 | +0.60 | 3,043,874 | 1.25 | 0.94 | |
| Nov 29, 2022 | $ 64.48 | $ 64.55 | $ 63.69 | $ 64.19 | -0.17 | 2,469,570 | 1.04 | 0.76 | 2 |
| Nov 28, 2022 | $ 64.81 | $ 65.15 | $ 64.09 | $ 64.36 | -0.74 | 3,310,621 | 1.44 | 1.02 | |
| Nov 25, 2022 | $ 64.70 | $ 65.24 | $ 64.70 | $ 65.10 | +0.44 | 2,154,069 | 0.97 | 0.66 | 1 |
| Nov 24, 2022 | $ 64.78 | $ 64.96 | $ 64.49 | $ 64.66 | -0.08 | 1,781,790 | 0.81 | 0.55 | |
| Nov 23, 2022 | $ 64.39 | $ 64.77 | $ 64.15 | $ 64.74 | +0.45 | 3,303,883 | 1.49 | 1.01 | 1 |
| Nov 22, 2022 | $ 64.00 | $ 64.53 | $ 64.00 | $ 64.29 | +0.32 | 2,135,617 | 0.97 | 0.65 | |
| Nov 21, 2022 | $ 63.54 | $ 64.03 | $ 63.54 | $ 63.97 | +0.41 | 2,241,944 | 1.04 | 0.68 |
Due Diligences
These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.
Did some searching into biopharma, seeing as markets are down at the moment, medical needs are still a necessity. According to Precedence Research, the global biopharmaceutical market was around US$ 265.4 billion in 2020. The main reasons behind this growth are the rising prevalence of chronic disea... Read More
Shining some much needed light on the BioPharma market during these turbulent times in the markets. Global biopharmaceutical sales are being spurred by several key drivers, including the growing prevalence of chronic diseases like cancer and diabetes, as well as the expanding global use of biopharma... Read More
Did some searching into biopharma, seeing as markets are down at the moment, medical needs are still a necessity. According to Precedence Research, the global biopharmaceutical market was around US$ 265.4 billion in 2020. The main reasons behind this growth are the rising prevalence of chronic disea... Read More
Shining some much needed light on the BioPharma market during these turbulent times in the markets. Global biopharmaceutical sales are being spurred by several key drivers, including the growing prevalence of chronic diseases like cancer and diabetes, as well as the expanding global use of biopharma... Read More
Shining some much needed light on the BioPharma market during these turbulent times in the markets. Global biopharmaceutical sales are being spurred by several key drivers, including the growing prevalence of chronic diseases like cancer and diabetes, as well as the expanding global use of biopharma... Read More
Quick Overview, Enlivex Therapeutics is a cutting-edge company that is focused on macrophage reprogramming. With their innovative company operations, they are developing and commercializing a drug pipeline for macrophage reprogramming in solid cancers, sepsis, and other indications. This company is... Read More
Quick Overview, Enlivex Therapeutics is a cutting-edge company that is focused on macrophage reprogramming. With their innovative company operations, they are developing and commercializing a drug pipeline for macrophage reprogramming in solid cancers, sepsis, and other indications. This company is... Read More
Top Discussions
These are the top discussions over the last 24-hours that mention the CM.TO stock ticker symbol.
@wsbdaily
wsbdaily